1. Home
  2. PDLB vs PGEN Comparison

PDLB vs PGEN Comparison

Compare PDLB & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$19.20

Market Cap

469.5M

Sector

N/A

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.76

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
PGEN
Founded
1960
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.5M
1.6B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
PDLB
PGEN
Price
$19.20
$4.76
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.33
AVG Volume (30 Days)
85.6K
4.9M
Earning Date
04-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
160.87
N/A
EPS
0.36
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
N/A
$1,115.92
Revenue Next Year
N/A
$81.04
P/E Ratio
$53.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.65
$1.40
52 Week High
$19.65
$5.47

Technical Indicators

Market Signals
Indicator
PDLB
PGEN
Relative Strength Index (RSI) 60.19 64.27
Support Level $15.93 $3.96
Resistance Level $19.42 $5.06
Average True Range (ATR) 0.56 0.29
MACD -0.01 0.10
Stochastic Oscillator 75.91 94.24

Price Performance

Historical Comparison
PDLB
PGEN

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: